Nanda Deepa Thimmappa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nanda Deepa Thimmappa has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Ayman H. Gaballah
The University of Texas MD Anderson Cancer Center, Houston, USA
4 shared publications - Ghassan M. Hammoud
Division of Gastroenterology and Hepatology, University of Missouri School of Medicine, One Hospital Drive, DC043.00, Columbia, MO 65212, USA
4 shared publications - Deepthi Rao
Division of Gastrointestinal Pathology, School of Medicine, University of Missouri, Columbia, MO 65212, USA
3 shared publications - Ahmad Hassan Ali
Division of Gastroenterology and Hepatology, University of Missouri School of Medicine, Columbia, Missouri, USA
2 shared publications - Irfan Amir Kazi
Department of Radiology, University of Missouri, Columbia, MO
2 shared publications - Jamal Ahmad Ibdah
Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO 65212, USA
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51  (12) , 6309-6319
A primer on the imaging approach to acute gastrointestinal bleeding
Acute gastrointestinal bleeding (GIB) is a common cause of emergency department presentation, with outcomes ranging from self-limited bleeding to potentially life-threatening hemorrhage. Based on location, acute GIB can be broadly categorized as upper gastrointestinal bleeding (UGIB), lower gastrointestinal bleeding (LGIB), or small-bowel bleeding (SBB). Understanding the clinical presentation and laboratory findings can help determine the appropriate next step in diagnostic evaluation and management. Imaging and endoscopy form the mainstay of evaluation and treatment. Multiphasic CT angiography (CTA), technetium-99 m–labeled red blood cell (RBC) scintigraphy, and catheter angiography are key imaging modalities in the workup of acute GIB. Recognition of common causes, appropriate modality selection, protocol optimization, and awareness of key interpretive pearls and pitfalls are essential for accurate radiologic interpretation and reporting, ultimately improving patient outcomes.
- 26 June 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51  (12) , 6309-6319
Open AccessA primer on the imaging approach to acute gastrointestinal bleeding
Acute gastrointestinal bleeding (GIB) is a common cause of emergency department presentation, with outcomes ranging from self-limited bleeding to potentially life-threatening hemorrhage. Based on location, acute GIB can be broadly categorized as upper gastrointestinal bleeding (UGIB), lower gastrointestinal bleeding (LGIB), or small-bowel bleeding (SBB). Understanding the clinical presentation and laboratory findings can help determine the appropriate next step in diagnostic evaluation and management. Imaging and endoscopy form the mainstay of evaluation and treatment. Multiphasic CT angiography (CTA), technetium-99 m–labeled red blood cell (RBC) scintigraphy, and catheter angiography are key imaging modalities in the workup of acute GIB. Recognition of common causes, appropriate modality selection, protocol optimization, and awareness of key interpretive pearls and pitfalls are essential for accurate radiologic interpretation and reporting, ultimately improving patient outcomes.
- Open Access
Predictors of Cirrhosis and Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: An Academic Center Experience
Background and goals: The outcomes of patients with primary sclerosing cholangitis (PSC) in central Missouri are unknown. The University of Missouri–Columbia services 600,000 individuals in central Missouri. Our aims were (a) to examine the outcomes of PSC patients receiving care at our academic institution, and (b) to identify the predictors of PSC-related serious adverse events. Methods: A retrospective study of patients with PSC in a non-transplant center. The primary outcome was the development of ≥1 of PSC-related serious adverse event for (1) progression to cirrhosis, or (2) development of cholangiocarcinoma. Results: From 2000 to 2018, 42 patients fulfilled the criteria for the diagnosis of PSC. A total of 55% of the patients were male, and 79% had associated inflammatory bowel disease (IBD). The median follow-up from time of diagnosis of PSC until the last follow-up or death was 5.5 years. A total of 57% of the patients developed ≥ 1 PSC-related adverse event; 36% (8/22) of those who progressed to decompensation underwent liver transplantation. The median time from diagnosis of PSC until progression to decompensation was 6.3 years; the median time from decompensation to transplantation was 10.8 years. A total of 12% of the patients developed ≥ 1 cancer (cholangiocarcinoma = 2; gallbladder cancer = 2; colon cancer = 1; and hepatocellular carcinoma = 1). The overall mortality was 9.5%. The median time from PSC diagnosis until death was 10.2 years. A Cox hazards regression analysis showed only age (HR = 1.16; p = 0.032; 95% CI, 1.01–1.13) and serum bilirubin (HR = 1.42; p = 0.036; 95% CI, 1.03–2.69) at the time of PSC diagnosis were independently associated with PSC-related serious events. Conclusions: Age and bilirubin are important predictors of PSC-related outcomes.
Open AccessPredictors of Cirrhosis and Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: An Academic Center Experience
Background and goals: The outcomes of patients with primary sclerosing cholangitis (PSC) in central Missouri are unknown. The University of Missouri–Columbia services 600,000 individuals in central Missouri. Our aims were (a) to examine the outcomes of PSC patients receiving care at our academic institution, and (b) to identify the predictors of PSC-related serious adverse events. Methods: A retrospective study of patients with PSC in a non-transplant center. The primary outcome was the development of ≥1 of PSC-related serious adverse event for (1) progression to cirrhosis, or (2) development of cholangiocarcinoma. Results: From 2000 to 2018, 42 patients fulfilled the criteria for the diagnosis of PSC. A total of 55% of the patients were male, and 79% had associated inflammatory bowel disease (IBD). The median follow-up from time of diagnosis of PSC until the last follow-up or death was 5.5 years. A total of 57% of the patients developed ≥ 1 PSC-related adverse event; 36% (8/22) of those who progressed to decompensation underwent liver transplantation. The median time from diagnosis of PSC until progression to decompensation was 6.3 years; the median time from decompensation to transplantation was 10.8 years. A total of 12% of the patients developed ≥ 1 cancer (cholangiocarcinoma = 2; gallbladder cancer = 2; colon cancer = 1; and hepatocellular carcinoma = 1). The overall mortality was 9.5%. The median time from PSC diagnosis until death was 10.2 years. A Cox hazards regression analysis showed only age (HR = 1.16; p = 0.032; 95% CI, 1.01–1.13) and serum bilirubin (HR = 1.42; p = 0.036; 95% CI, 1.03–2.69) at the time of PSC diagnosis were independently associated with PSC-related serious events. Conclusions: Age and bilirubin are important predictors of PSC-related outcomes.
- Open Access
- 5 February 2026
- Published by MDPI AG in Preprints.org
Predictors of Cirrhosis and Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: An Academic Center Experience
Background and goals: Outcomes of patients with primary sclerosing cholangitis (PSC) in Central Missouri are unknown. The University of Missouri-Columbia services 600,000 individuals in Central Missouri. Our aims were to a) examine the outcomes of PSC patients receiving care at our academic institution, and b) identify predictors of PSC-related serious adverse events. Methods: A retrospective study of patients with PSC in a non-transplant center. Primary outcome was development of ≥ 1 of PSC-related serious adverse event: 1) progression to cirrhosis, or 2) development of cholangiocarcinoma. Results: From year 2000 to 2018, 42 patients fulfilled the criteria for the diagnosis of PSC. 55% were male, 79% had associated inflammatory bowel disease (IBD). The median follow-up from time of diagnosis of PSC until last follow up or death was 5.5 years. Fifty-seven percent of patients developed ≥1 PSC-related adverse event; 36% (8/22) of those who progressed to decompensation underwent liver transplantation. The median time from diagnosis of PSC until progression to decompensation was 6.3 years. The median time from decompensation to transplantation was 10.8 years. Twelve percent developed ≥1 cancer (cholangiocarcinoma=2; gallbladder cancer=2; colon cancer =1; and hepatocellular carcinoma =1). The overall mortality was 9.5%. The median time from PSC diagnosis until death was 10.2 years. Cox hazards regression analysis showed only age (HR=1.05; p=0.028; 95% CI, 1.01-1.11) and serum bilirubin (HR= 1.55; p=0.033; 95% CI, 1.03-2.28) at the time of PSC diagnosis. Conclusion: Age and bilirubin are important predictors of PSC-related outcomes.
- 5 February 2026
- Published by MDPI AG in Preprints.org
Open AccessPredictors of Cirrhosis and Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: An Academic Center Experience
Background and goals: Outcomes of patients with primary sclerosing cholangitis (PSC) in Central Missouri are unknown. The University of Missouri-Columbia services 600,000 individuals in Central Missouri. Our aims were to a) examine the outcomes of PSC patients receiving care at our academic institution, and b) identify predictors of PSC-related serious adverse events. Methods: A retrospective study of patients with PSC in a non-transplant center. Primary outcome was development of ≥ 1 of PSC-related serious adverse event: 1) progression to cirrhosis, or 2) development of cholangiocarcinoma. Results: From year 2000 to 2018, 42 patients fulfilled the criteria for the diagnosis of PSC. 55% were male, 79% had associated inflammatory bowel disease (IBD). The median follow-up from time of diagnosis of PSC until last follow up or death was 5.5 years. Fifty-seven percent of patients developed ≥1 PSC-related adverse event; 36% (8/22) of those who progressed to decompensation underwent liver transplantation. The median time from diagnosis of PSC until progression to decompensation was 6.3 years. The median time from decompensation to transplantation was 10.8 years. Twelve percent developed ≥1 cancer (cholangiocarcinoma=2; gallbladder cancer=2; colon cancer =1; and hepatocellular carcinoma =1). The overall mortality was 9.5%. The median time from PSC diagnosis until death was 10.2 years. Cox hazards regression analysis showed only age (HR=1.05; p=0.028; 95% CI, 1.01-1.11) and serum bilirubin (HR= 1.55; p=0.033; 95% CI, 1.03-2.28) at the time of PSC diagnosis. Conclusion: Age and bilirubin are important predictors of PSC-related outcomes.
- 17 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51  (2) , 889-900
Magnetic resonance urography (MRU): technique mastery and illustrative case reviews
Magnetic Resonance Urography (MRU) is a comprehensive, non-invasive imaging technique that offers detailed anatomical and functional assessment of the urinary system without radiation exposure. It is particularly valuable in pediatric, pregnant, and renally impaired patients, and in those with CT contrast allergies. Multiparametric MRU sequences can evaluate congenital anomalies, functional obstruction, urothelial tumors, and postoperative anatomy. Advancements in imaging technology such as respiratory gating, compressed sensing, and motion correction, have significantly improved image quality and patient comfort. The introduction of the Vesical Imaging Reporting and Data System (VI-RADS) has standardized bladder cancer staging, aiding in inter-reader reproducibility and treatment planning. This review outlines MRU technique, protocol optimization, artifact mitigation strategies, and specific pediatric and oncologic applications. Illustrative cases highlight the versatility of MRU in clinical practice. With advanced MRI techniques, increasing expertise among radiologists and familiarity among urologists, MRU is emerging as a first-line modality in select urologic conditions.
- 17 July 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51  (2) , 889-900
Magnetic resonance urography (MRU): technique mastery and illustrative case reviews
Magnetic Resonance Urography (MRU) is a comprehensive, non-invasive imaging technique that offers detailed anatomical and functional assessment of the urinary system without radiation exposure. It is particularly valuable in pediatric, pregnant, and renally impaired patients, and in those with CT contrast allergies. Multiparametric MRU sequences can evaluate congenital anomalies, functional obstruction, urothelial tumors, and postoperative anatomy. Advancements in imaging technology such as respiratory gating, compressed sensing, and motion correction, have significantly improved image quality and patient comfort. The introduction of the Vesical Imaging Reporting and Data System (VI-RADS) has standardized bladder cancer staging, aiding in inter-reader reproducibility and treatment planning. This review outlines MRU technique, protocol optimization, artifact mitigation strategies, and specific pediatric and oncologic applications. Illustrative cases highlight the versatility of MRU in clinical practice. With advanced MRI techniques, increasing expertise among radiologists and familiarity among urologists, MRU is emerging as a first-line modality in select urologic conditions.
- Open Access
- 26 April 2025
- Published by Oxford University Press (OUP) in Radiology Advances
- Vol. 2  (3) , umaf018
Quantifying changes in steatotic liver disease after bariatric surgery using ultrasound-derived fat fraction
Background: A noninvasive, readily accessible, and quantitative methods are needed to evaluate changes in hepatic fat over time in patients undergoing bariatric surgery. Purpose: To measure the change in ultrasound-derived fat fraction (UDFF) in severely obese adults before and after bariatric surgery. Materials and Methods: Participants undergoing bariatric surgery were prospectively enrolled at a single center and evaluated at 3 time points: pre-surgery (before a 2-week pre-operative liquid diet), day of surgery (immediately following the liquid diet), and 6 months post-surgery. Measurements included UDFF (Siemens Healthineers ACUSON SEQUOIA), skin-to-liver capsule thickness, serum metabolic tests, liver function tests, and anthropometric data. Changes in these variables were analyzed using 2-sided paired t-tests. Pearson correlation analysis was used to evaluate associations between changes in UDFF and changes in skin-to-capsule thickness, waist circumference, and BMI. Results: Seventeen participants (mean age 47.41 ± 11.11 years, 15 women) completed the study. UDFF (mean ± SD) decreased significantly from 20.4 ± 8.41% pre-surgery to 11.08 ± 6.33% at 6 months post-surgery (P < .001). Skin-to-liver capsule thickness decreased from 4.06 ± 0.66 cm to 2.88 ± 0.55 cm (P < .001). BMI decreased from 46.27 ± 6.65 kg/m2 to 35.5 ± 6.64 kg/m2 (P < .001), and waist circumference decreased from 130.29 ± 13.49 cm to 111.98 ± 16.03 cm (P < .001). No significant changes were observed in UDFF, skin-to-liver capsule thickness, or waist circumference after the liquid diet phase. Strong positive correlation between UDFF and BMI reduction was observed (r = 0.75, P < .001). Conclusions: Bariatric surgery results in significant reductions in hepatic steatosis, as measured by UDFF, and reductions in skin-to-liver capsule thickness, BMI, and waist circumference at 6 months post-surgery. These findings suggest that UDFF could meet the clinical need for noninvasive monitoring of hepatic steatosis following bariatric surgery.
- 26 April 2025
- Published by Oxford University Press (OUP) in Radiology Advances
- Vol. 2  (3) , umaf018
Open AccessQuantifying changes in steatotic liver disease after bariatric surgery using ultrasound-derived fat fraction
Background: A noninvasive, readily accessible, and quantitative methods are needed to evaluate changes in hepatic fat over time in patients undergoing bariatric surgery. Purpose: To measure the change in ultrasound-derived fat fraction (UDFF) in severely obese adults before and after bariatric surgery. Materials and Methods: Participants undergoing bariatric surgery were prospectively enrolled at a single center and evaluated at 3 time points: pre-surgery (before a 2-week pre-operative liquid diet), day of surgery (immediately following the liquid diet), and 6 months post-surgery. Measurements included UDFF (Siemens Healthineers ACUSON SEQUOIA), skin-to-liver capsule thickness, serum metabolic tests, liver function tests, and anthropometric data. Changes in these variables were analyzed using 2-sided paired t-tests. Pearson correlation analysis was used to evaluate associations between changes in UDFF and changes in skin-to-capsule thickness, waist circumference, and BMI. Results: Seventeen participants (mean age 47.41 ± 11.11 years, 15 women) completed the study. UDFF (mean ± SD) decreased significantly from 20.4 ± 8.41% pre-surgery to 11.08 ± 6.33% at 6 months post-surgery (P < .001). Skin-to-liver capsule thickness decreased from 4.06 ± 0.66 cm to 2.88 ± 0.55 cm (P < .001). BMI decreased from 46.27 ± 6.65 kg/m2 to 35.5 ± 6.64 kg/m2 (P < .001), and waist circumference decreased from 130.29 ± 13.49 cm to 111.98 ± 16.03 cm (P < .001). No significant changes were observed in UDFF, skin-to-liver capsule thickness, or waist circumference after the liquid diet phase. Strong positive correlation between UDFF and BMI reduction was observed (r = 0.75, P < .001). Conclusions: Bariatric surgery results in significant reductions in hepatic steatosis, as measured by UDFF, and reductions in skin-to-liver capsule thickness, BMI, and waist circumference at 6 months post-surgery. These findings suggest that UDFF could meet the clinical need for noninvasive monitoring of hepatic steatosis following bariatric surgery.
- Open Access
- 28 June 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50  (1) , 109-130
Post-operative complications of cholecystectomy: what the radiologist needs to know
Cholecystectomy is one of the most performed surgical procedures. The safety of this surgery notwithstanding, the sheer volume of operations results in a notable incidence of post-cholecystectomy complications. Early and accurate diagnosis of such complications is essential for timely and effective management. Imaging techniques are critical for this purpose, aiding in distinguishing between expected postsurgical changes and true complications. This review highlights current knowledge on the indications for cholecystectomy, pertinent surgical anatomy and surgical technique, and the recognition of anatomical variants that may complicate surgery. The article also outlines the roles of various imaging modalities in identifying complications, the spectrum of possible postsurgical anatomical changes, and the implications of such findings. Furthermore, we explore the array of complications that can arise post-cholecystectomy, such as biliary system injuries, gallstone-related issues, vascular complications, and the formation of postsurgical collections. Radiologists should be adept at identifying normal and abnormal postoperative findings to guide patient management effectively. Graphical abstract
- 28 June 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50  (1) , 109-130
Open AccessPost-operative complications of cholecystectomy: what the radiologist needs to know
Cholecystectomy is one of the most performed surgical procedures. The safety of this surgery notwithstanding, the sheer volume of operations results in a notable incidence of post-cholecystectomy complications. Early and accurate diagnosis of such complications is essential for timely and effective management. Imaging techniques are critical for this purpose, aiding in distinguishing between expected postsurgical changes and true complications. This review highlights current knowledge on the indications for cholecystectomy, pertinent surgical anatomy and surgical technique, and the recognition of anatomical variants that may complicate surgery. The article also outlines the roles of various imaging modalities in identifying complications, the spectrum of possible postsurgical anatomical changes, and the implications of such findings. Furthermore, we explore the array of complications that can arise post-cholecystectomy, such as biliary system injuries, gallstone-related issues, vascular complications, and the formation of postsurgical collections. Radiologists should be adept at identifying normal and abnormal postoperative findings to guide patient management effectively. Graphical abstract
- 17 August 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59  (3) , 797-811
MRA for Preoperative Planning and Postoperative Management of Perforator Flap Surgeries: A Review
Perforator flap magnetic resonance angiography (MRA) has emerged as a widely accepted and preferred modality for perforator flap mapping at several institutions. Autologous perforator flaps are a type of reconstructive microsurgical technique that involves transferring skin and fat from one part of the patient's body to another to replace tissue lost due to trauma, cancer resection, or other reasons. Autologous perforator flaps are based on a specific perforating blood vessel perfusing the transferred tissue. Hence, the surgery relies on the precise identification and mapping of perforating vessels to ensure successful outcomes. With its superior soft tissue contrast and multiplanar imaging capabilities, MRA has shown great potential in providing accurate and detailed visualization of perforator anatomy, size, and course. This review article summarizes the current literature on perforator flap MRA, including its technical considerations, imaging protocols, postprocessing, and reporting, specifically for autologous breast reconstructions. The advantages and limitations of MRA in evaluating perforator flaps are discussed, including its role in preoperative planning, intraoperative guidance, and postoperative assessment. Anatomy, brief surgical technique, specific technical modifications, and reporting of most commonly performed autologous breast flaps are described. Recent advancements in Perforator flap surgery and MRA techniques are discussed. Additionally, we examine the emerging role of artificial intelligence and machine learning in improving the accuracy and efficiency of perforator flap MRA interpretation.Level of Evidence: 5Technical Efficacy: Stage 5
- 17 August 2023
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 59  (3) , 797-811
MRA for Preoperative Planning and Postoperative Management of Perforator Flap Surgeries: A Review
Perforator flap magnetic resonance angiography (MRA) has emerged as a widely accepted and preferred modality for perforator flap mapping at several institutions. Autologous perforator flaps are a type of reconstructive microsurgical technique that involves transferring skin and fat from one part of the patient's body to another to replace tissue lost due to trauma, cancer resection, or other reasons. Autologous perforator flaps are based on a specific perforating blood vessel perfusing the transferred tissue. Hence, the surgery relies on the precise identification and mapping of perforating vessels to ensure successful outcomes. With its superior soft tissue contrast and multiplanar imaging capabilities, MRA has shown great potential in providing accurate and detailed visualization of perforator anatomy, size, and course. This review article summarizes the current literature on perforator flap MRA, including its technical considerations, imaging protocols, postprocessing, and reporting, specifically for autologous breast reconstructions. The advantages and limitations of MRA in evaluating perforator flaps are discussed, including its role in preoperative planning, intraoperative guidance, and postoperative assessment. Anatomy, brief surgical technique, specific technical modifications, and reporting of most commonly performed autologous breast flaps are described. Recent advancements in Perforator flap surgery and MRA techniques are discussed. Additionally, we examine the emerging role of artificial intelligence and machine learning in improving the accuracy and efficiency of perforator flap MRA interpretation.Level of Evidence: 5Technical Efficacy: Stage 5
- 1 October 2021
- Published by Elsevier in Clinical Imaging
- Vol. 78, 113-116
Cystic dystrophy of the duodenal wall: case report and literature review
- 1 October 2021
- Published by Elsevier in Clinical Imaging
- Vol. 78, 113-116
Cystic dystrophy of the duodenal wall: case report and literature review
- Open Access
- 1 March 2021
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 47  (2) , 472-473
REPLY TO THE AUTHORS: Re: Ureteroinguinal hernia with obstructive urolithiasis
Although there are no known risk factors for uretero-inguinal hernias we note that BMI could attribute and this patient had a BMI of 45, classified as morbid obesity (1, 2). There are other cases of this rare hernia that were also observed in males with extremely high BMI (3). Management of any obstruction can be a challenge in this individual with anatomic complexity and other options may need to be considered including longer stent lengths and even antegrade ureteral access via nephrostomy tube. This patient was successfully managed with retrograde ureteroscopy with holmium laser lithotripsy of his stone and placement of a 6 French x 30 cm double-J ureteral stent. This was the longest stent size available and it was unable to completely reach the renal pelvis but was left for 3 days post-operatively to prevent distal ureteral obstruction after procedure. Although it is a rare occurrence, the availability of extra-long stents in hospitals may be necessary. To date, there has been no recurrence of urolithiasis for the patient but continued monitoring with intermittent imaging will be a necessity.
- 1 March 2021
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 47  (2) , 472-473
Open AccessREPLY TO THE AUTHORS: Re: Ureteroinguinal hernia with obstructive urolithiasis
Although there are no known risk factors for uretero-inguinal hernias we note that BMI could attribute and this patient had a BMI of 45, classified as morbid obesity (1, 2). There are other cases of this rare hernia that were also observed in males with extremely high BMI (3). Management of any obstruction can be a challenge in this individual with anatomic complexity and other options may need to be considered including longer stent lengths and even antegrade ureteral access via nephrostomy tube. This patient was successfully managed with retrograde ureteroscopy with holmium laser lithotripsy of his stone and placement of a 6 French x 30 cm double-J ureteral stent. This was the longest stent size available and it was unable to completely reach the renal pelvis but was left for 3 days post-operatively to prevent distal ureteral obstruction after procedure. Although it is a rare occurrence, the availability of extra-long stents in hospitals may be necessary. To date, there has been no recurrence of urolithiasis for the patient but continued monitoring with intermittent imaging will be a necessity.